190 related articles for article (PubMed ID: 2440021)
1. Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.
Huhn RD; Posner MR; Rayter SI; Foulkes JG; Frackelton AR
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4408-12. PubMed ID: 2440021
[TBL] [Abstract][Full Text] [Related]
2. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
3. Phosphotyrosine phosphatase activity prevents the detection of P210bcr/abl protein in mature cells in chronic myelogenous leukemia even by an immunoblotting technique.
Shibata K; Nishimura J; Takahira H; Nawata H
Leukemia; 1989 Sep; 3(9):615-9. PubMed ID: 2474729
[TBL] [Abstract][Full Text] [Related]
4. Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells.
Naldini L; Stacchini A; Cirillo DM; Aglietta M; Gavosto F; Comoglio PM
Mol Cell Biol; 1986 May; 6(5):1803-11. PubMed ID: 2431286
[TBL] [Abstract][Full Text] [Related]
5. Differences in tyrosine phosphorylated proteins between cells expressing P210bcr/abl and P190bcr/abl.
Nishimura J; Shibata K; Sadamura S; Takahira H; Hirata J; Umemura T; Nawata H; Okamura J
Int J Hematol; 1992 Jun; 55(3):227-33. PubMed ID: 1379843
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylated proteins in chronic myelogenous leukemia.
Frackelton AR; Kumar PS; Kannan B; Clark JW
Leuk Lymphoma; 1993; 11 Suppl 1():125-9. PubMed ID: 7504542
[TBL] [Abstract][Full Text] [Related]
7. Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method.
Kuwao F; Takahashi I
Leukemia; 1993 Aug; 7(8):1168-73. PubMed ID: 8350617
[TBL] [Abstract][Full Text] [Related]
8. A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.
Freed E; Hunter T
Mol Cell Biol; 1992 Mar; 12(3):1312-23. PubMed ID: 1545812
[TBL] [Abstract][Full Text] [Related]
9. Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells.
Nichols GL; Raines MA; Vera JC; Lacomis L; Tempst P; Golde DW
Blood; 1994 Nov; 84(9):2912-8. PubMed ID: 7524758
[TBL] [Abstract][Full Text] [Related]
10. A novel 53 kDa protein complexed with P210bcr-abl in human chronic myelogenous leukemia cells.
Li WJ; Kloetzer WS; Arlinghaus RB
Oncogene; 1988 Jun; 2(6):559-66. PubMed ID: 3133627
[TBL] [Abstract][Full Text] [Related]
11. Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL.
Salgia R; Brunkhorst B; Pisick E; Li JL; Lo SH; Chen LB; Griffin JD
Oncogene; 1995 Sep; 11(6):1149-55. PubMed ID: 7566975
[TBL] [Abstract][Full Text] [Related]
12. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia.
Wisniewski D; Strife A; Berman E; Clarkson B
Leukemia; 1996 Feb; 10(2):229-37. PubMed ID: 8637231
[TBL] [Abstract][Full Text] [Related]
13. Reduction in protein tyrosine phosphorylation during differentiation of human leukemia cell line K-562.
Richardson JM; Morla AO; Wang JY
Cancer Res; 1987 Aug; 47(15):4066-70. PubMed ID: 2440557
[TBL] [Abstract][Full Text] [Related]
14. Crkl is the major tyrosine-phosphorylated protein in neutrophils from patients with chronic myelogenous leukemia.
Oda T; Heaney C; Hagopian JR; Okuda K; Griffin JD; Druker BJ
J Biol Chem; 1994 Sep; 269(37):22925-8. PubMed ID: 8083188
[TBL] [Abstract][Full Text] [Related]
15. A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.
Wisniewski D; Strife A; Wojciechowicz D; Lambek C; Clarkson B
Leukemia; 1994 Apr; 8(4):688-93. PubMed ID: 8152267
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
[TBL] [Abstract][Full Text] [Related]
18. Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin.
Oda A; Miyakawa Y; Druker BJ; Ishida A; Ozaki K; Ohashi H; Wakui M; Handa M; Watanabe K; Okamoto S; Ikeda Y
Blood; 1996 Dec; 88(11):4304-13. PubMed ID: 8943867
[TBL] [Abstract][Full Text] [Related]
19. Regulation of biosynthesis and phosphorylation of P210bcr/abl protein during differentiation induction of K 562 cells.
Nishimura J; Takahira H; Shibata K; Muta K; Yamamoto M; Ideguchi H; Umemura T; Nawata H
Leuk Res; 1988; 12(11-12):875-85. PubMed ID: 2464113
[TBL] [Abstract][Full Text] [Related]
20. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line.
Carlesso N; Griffin JD; Druker BJ
Oncogene; 1994 Jan; 9(1):149-56. PubMed ID: 8302574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
